Lucid Diagnostics Inc (LUCD) Stock Price, Quote & News

Company Profile

Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company in the United States. It focuses on patients with gastroesophageal reflux disease (GERD) who are at risk of developing esophageal precancer and cancer, primarily highly lethal esophageal adenocarcinoma. The company's flagship product, the EsoGuard Esophageal DNA Test performed on samples collected with the EsoCheck Esophageal Cell collection device, a testing tool with the goal of preventing EAC deaths t...

Industry: Medical Devices

Sector: Healthcare

Phone: 917 813 1828

Website: www.luciddx.com

Address:

360 Madison Avenue, 25th Floor, New York, United States

alexpitti Jul. 17 at 5:15 PM

$LUCD i have read 33/43 pages of cac meeting

1 · Reply

crypto_biotech Jul. 17 at 4:39 PM

$LUCD Going to buy a shit ton next Wednesday. If Thursday NO GO- selling it for wash, rinse, repeat profits. Imminent? Whatever

2 · Reply

Researchpro Jul. 17 at 2:42 PM

$LUCD well atleast there is more volume on the ask. We have seen this much volume in a while. Hopefully MolDx wakes up.

0 · Reply

JRINPHX Jul. 17 at 1:55 PM

$LUCD complete horse shit. 💩

0 · Reply

alexpitti Jul. 17 at 1:14 PM

someone from a community college can easily read the cac transcript and grant an LCD to LUCID. i have almost finished reading $LUCD

1 · Reply

dudereally Jul. 17 at 12:34 PM

$LUCD using resumes to fleece investors for giant salaries and produce promises instead of revenue!

1 · Reply

alexpitti Jul. 17 at 4:41 AM

$LUCD wow the ceo of lucid invented angiovac. that's really awesome

1 · Reply

oaksapollo Jul. 16 at 11:20 PM

$LUCD https://investor.natera.com/news/news-details/2026/Finalized-MolDx-LCD-Includes-Expanded-Coverage-for-Nateras-Prospera-Portfolio/default.aspx Makes sense that this took priority over Eso, they got a draft July 2025 and have been waiting a full year for effective coverage. Hopefully Moldx is running out of things that are higher priority than Eso.

3 · Reply

alexpitti Jul. 16 at 7:25 PM

Buying a stock at 99 cents and checking at 2am Thursday sounds like gambling $LUCD

2 · Reply

am2 Jul. 16 at 6:59 PM

$LUCD I went back and re-read the bios of the $LUCD leadership team. That is quite an impressive group of people leading a small company. The company itself lacks the kind of financial resources and industry connections to carry out its marketing efforts in a highly effective way. And, this fact may be recognized by a larger and well-funded entity which could enter the picture (e.g., either partner or simply buy $LUCD). I'd be interested to hear from fellow longs about the odds of a buyout.

1 · Reply

Lucid Diagnostics Transcript: AGM 2026

Jun 12, 2026, 7:00 AM EDT - 5 weeks ago

Lucid Diagnostics Slides: Investor presentation

2026-05-15T15:26:45.000Z - 2 months ago

Lucid Diagnostics price target lowered to $2 from $3 at Maxim

May 15, 2026, 8:00 AM EDT - 2 months ago

Market Cap	233.53M
Revenue (ttm)	4.71M
Net Income (ttm)	-58.01M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-1,231.63%
Debt to Equity Ratio	6.30

Volume	1,479,891
Avg Vol	1,433,214
Day's Range	N/A - N/A
Shares Out	203.07M
Stochastic %K	23%
Beta	1.07
Analysts	Strong Sell
Price Target	$3.95